Helen Prunty

589 total citations
19 papers, 356 citations indexed

About

Helen Prunty is a scholar working on Molecular Biology, Clinical Biochemistry and Rheumatology. According to data from OpenAlex, Helen Prunty has authored 19 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Clinical Biochemistry and 7 papers in Rheumatology. Recurrent topics in Helen Prunty's work include Metabolism and Genetic Disorders (7 papers), Lysosomal Storage Disorders Research (6 papers) and Amino Acid Enzymes and Metabolism (5 papers). Helen Prunty is often cited by papers focused on Metabolism and Genetic Disorders (7 papers), Lysosomal Storage Disorders Research (6 papers) and Amino Acid Enzymes and Metabolism (5 papers). Helen Prunty collaborates with scholars based in United Kingdom, United States and Sweden. Helen Prunty's co-authors include Andrew J. Copp, Dawn Savery, Simon Heales, Nicholas D. E. Greene, Kit‐Yi Leung, John T. Brosnan, Tim Hutchin, Margaret E. Brosnan, Yun Jin Pai and Simon Heales and has published in prestigious journals such as Nature Communications, The American Journal of Human Genetics and British Journal of Clinical Pharmacology.

In The Last Decade

Helen Prunty

18 papers receiving 354 citations

Peers

Helen Prunty

RHEUM

PHYSI

PPCH

Mark Sharrard United Kingdom

Mike Champion United Kingdom

Marina Morath Germany

Serap Sivri Türkiye

Norma Spécola Argentina

Anke Schumann Germany

Sravan Jaggumantri Canada

Danijela Petković Ramadža Croatia

A. E. M. Stroomer Netherlands

F. J. van Spronsen Netherlands

Mark Sharrard United Kingdom

Helen Prunty

212 ×1.3

178 ×1.1

116 ×1.0

RHEUM

73 ×0.9

PHYSI

66 ×1.0

PPCH

Citations per year, relative to Helen Prunty Helen Prunty (= 1×) peers Mark Sharrard

Countries citing papers authored by Helen Prunty

Since Specialization

Citations

This map shows the geographic impact of Helen Prunty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Prunty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Prunty more than expected).

Fields of papers citing papers by Helen Prunty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Prunty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Prunty. The network helps show where Helen Prunty may publish in the future.

Co-authorship network of co-authors of Helen Prunty

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Prunty. A scholar is included among the top collaborators of Helen Prunty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Prunty. Helen Prunty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Prunty, Helen, John R. Counsell, Anna Karlsson, et al.. (2024). Gene therapy prevents hepatic mitochondrial dysfunction in murine deoxyguanosine kinase deficiency. Molecular Therapy — Methods & Clinical Development. 33(1). 101397–101397. 1 indexed citations

Grünewald, Stephanie, et al.. (2023). Clinical experience with glycerol phenylbutyrate in 20 patients with urea cycle disorders at a UK paediatric centre. JIMD Reports. 64(5). 317–326. 4 indexed citations

Grünewald, Stephanie, et al.. (2022). Direct replacement of oral sodium benzoate with glycerol phenylbutyrate in children with urea cycle disorders. JIMD Reports. 63(2). 137–145. 4 indexed citations

Leung, Kit‐Yi, Sandra C. de Castro, Dawn Savery, et al.. (2020). Regulation of glycine metabolism by the glycine cleavage system and conjugation pathway in mouse models of non‐ketotic hyperglycinemia. Journal of Inherited Metabolic Disease. 43(6). 1186–1198. 18 indexed citations

Stuckey, Daniel J., Derek Burke, Helen Prunty, et al.. (2020). Lentiviral Hematopoietic Stem Cell Gene Therapy Rescues Clinical Phenotypes in a Murine Model of Pompe Disease. Molecular Therapy — Methods & Clinical Development. 18. 558–570. 9 indexed citations

Chiesa, Robert, et al.. (2020). Modelling of neutrophil dynamics in children receiving busulfan or treosulfan for haematopoietic stem cell transplant conditioning. British Journal of Clinical Pharmacology. 86(8). 1537–1549. 4 indexed citations

Heales, Simon, Katie Harvey, Maureen Cleary, et al.. (2019). Urinary glucose tetrasaccharide, a useful prognostic biomarker for Pompe disease?. Molecular Genetics and Metabolism. 126(2). S70–S70. 1 indexed citations

Meyer, Rosan, Claire De Koker, Heather Godwin, et al.. (2018). The prevalence of lactose intolerance in children with non-IgE-mediated gastrointestinal cow’s milk protein allergy. 1 indexed citations

Broomfield, Alexander, Pauline Hensman, Ronnie Wright, et al.. (2017). Rapidly Progressive White Matter Involvement in Early Childhood: The Expanding Phenotype of Infantile Onset Pompe?. JIMD Reports. 39. 55–62. 23 indexed citations

10.

Chiesa, Robert, Joseph F. Standing, Robert B. Winter, et al.. (2017). 65 Phase ii trial to define the therapeutic index of treosulfan for myeloablative conditioning in haematopoietic stem cell transplant. HighWire Press Open Archive. A23.1–A23.

11.

Darín, Niklas, Emma Reid, Laurence Prunetti, et al.. (2016). Mutations in PROSC Disrupt Cellular Pyridoxal Phosphate Homeostasis and Cause Vitamin-B6-Dependent Epilepsy. The American Journal of Human Genetics. 99(6). 1325–1337. 106 indexed citations

12.

Prunty, Helen, et al.. (2015). Improved method for the analysis of urinary glucose tetrasaccharide (Glc4) by high pressure liquid chromatography (HPLC). Molecular Genetics and Metabolism. 114(2). S97–S97. 1 indexed citations

13.

Pai, Yun Jin, Kit‐Yi Leung, Dawn Savery, et al.. (2015). Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice. Nature Communications. 6(1). 6388–6388. 104 indexed citations

14.

Baruteau, Julien, Iain P. Hargreaves, S. Krywawych, et al.. (2014). Successful reversal of propionic acidaemia associated cardiomyopathy: Evidence for low myocardial coenzyme Q10 status and secondary mitochondrial dysfunction as an underlying pathophysiological mechanism. Mitochondrion. 17. 150–156. 36 indexed citations

15.

Prunty, Helen, Alexander Broomfield, Ashok Vellodi, et al.. (2014). Update on glucose tetrasaccharide (Glc4) in urine and saliva as a potential biomarker in Pompe disease. Molecular Genetics and Metabolism. 111(2). S88–S88. 1 indexed citations

16.

Harvey, Katie, et al.. (2013). Glucose tetrasaccharide as a biomarker in Pompe disease and other glycogen storage diseases. Molecular Genetics and Metabolism. 108(2). S47–S47. 1 indexed citations

17.

Prunty, Helen, et al.. (2011). Urine analysis of glucose tetrasaccharide by HPLC; a useful marker for the investigation of patients with Pompe and other glycogen storage diseases. Journal of Inherited Metabolic Disease. 35(2). 311–316. 31 indexed citations

18.

Moat, Stuart J., Rachel S. Carling, Michael Henderson, et al.. (2010). Multicentre age-related reference intervals for cerebrospinal fluid serine concentrations: Implications for the diagnosis and follow-up of serine biosynthesis disorders. Molecular Genetics and Metabolism. 101(2-3). 149–152. 8 indexed citations

19.

Prunty, Helen, et al.. (2004). Sweat patch cortisol - a new screen for Cushing's syndrome. 347. 123716–123716. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact